![C48H54N7O8P Adenosin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI)](http://cdn.globalso.com/nvchem/style/global/img/demo/page_banner.jpg)
![C48H54N7O8P Adenosin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI) Ausgezeechent Bild](https://www.csnvchem.com/uploads/C48H54N7O8P.png)
C48H54N7O8P Adenosin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI)
CAS Registréierungsnummer
110782-31-5
H335, H331, H319, H315, H311, H301+H311+H331, H301
| Schlëssel kierperlech Eegeschaften | Wäert | Zoustand |
| Molekulare Gewiicht | 887,96 | - |
| pKa (virausgesot) | 7,87±0,43 | Déi meescht sauer Temperatur: 25 °C |
Kanonesch SMILES
N#CCCOP(OC1C(OC(N2C= NC=3C(= NC= NC32)NC(=O)C=4C=CC=CC4)C1OC)COC(C=5C=CC=CC5)(C6=CC=C (OC)C=C6)C7=CC=C(OC)C=C7)N(C(C)C)C(C)C
Isomeric SMILES
C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OC)[C@@ H](O1)N2C=3C(N=C2)=C(NC(=O)C4=CC=CC=C4)N=CN3)(C5=CC= C(OC)C=C5)(C6=CC=C(OC)C=C6)C7=CC=CC=C7
InChI
InChI= 1S/C48H54N7O8P/c1-32(2)55(33(3)4)64(61-28-14-27-49)63-42-40(62-47(43(42)59-7)54- 31-52-41-44(50-30-51-45(41)54)53-46(5) 6) 34-15-10-8-11-16-34) 29-60-48 (35-17-12-9-13-18-35,36-19-23-38 (57-5)24-20-36)37-21-25-39(58-6)26-22-37/h8-13,15-26,30-33,40,4 2-43,47H,14,28-29H2,1-7H3,(H,50,51,53,56)/t40-,42-,43-,47-,64?/m1/s1
InChI Schlëssel
AZCGOTUYEPXHMJ-PSVHYZMASA-N
2 Aner Nimm fir dës Substanz
Adenosin,N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'- [2-cyanoethyl bis(1-methylethyl)phosphoramidit] (9CI); 5′ -O-(4,4'-dimethoxytrityl)-N6-benzoyl-2'-O-methyladenosin 3'- (2-cyanoethylN,N-diisopropylphosphoramidit)
Spektrum verfügbar
13 C NMR
Hetero NMR
Mass
Eegeschafte verfügbar
Biologesch
Chemesch
Lipinski
Struktur Zesummenhang
| Immobilie | Wäert | Zoustand | Quell |
| Biokonzentratiounsfaktor | 4050 | pH 1; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,08 x 105 | pH 2; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 3; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 4; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 5; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 6; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 7; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 8; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 2,10 x 105 | pH 9; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 6 0800 | pH 10; Temperatur: 25 °C | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Zoustand | Quell |
| Koc | 1830 | pH 1; Temperatur: 25 °C | (1) ACD |
| Koc | 48700 | pH 2; Temperatur: 25 °C | (1) ACD |
| Koc | 4,91 x 105 | pH 3; Temperatur: 25 °C | (1) ACD |
| Koc | 1,52 x 106 | pH 4; Temperatur: 25 °C | (1) ACD |
| Koc | 1,90 x 106 | pH 5; Temperatur: 25 °C | (1) ACD |
| Koc | 1,91 x 106 | pH 6; Temperatur: 25 °C | (1) ACD |
| Koc | 1,57 x 106 | pH 7; Temperatur: 25 °C | (1) ACD |
| Immobilie | Wäert | Zoustand | Quell |
| Koc | 5,78 x 105 | pH 8; Temperatur: 25 °C | (1) ACD |
| Koc | 95000 | pH 9; Temperatur: 25 °C | (1) ACD |
| Koc | 27500 | pH 10; Temperatur: 25 °C | (1) ACD |
| log D | 6.01 | pH 1; Temperatur: 25 °C | (1) ACD |
| log D | 7.43 | pH 2; Temperatur: 25 °C | (1) ACD |
| log D | 8.44 | pH 3; Temperatur: 25 °C | (1) ACD |
| log D | 8,93 | pH 4; Temperatur: 25 °C | (1) ACD |
| log D | 9.02 | pH 5; Temperatur: 25 °C | (1) ACD |
| log D | 9.02 | pH 6; Temperatur: 25 °C | (1) ACD |
| log D | 8,94 | pH 7; Temperatur: 25 °C | (1) ACD |
| log D | 8,51 | pH 8; Temperatur: 25 °C | (1) ACD |
| log D | 7.72 | pH 9; Temperatur: 25 °C | (1) ACD |
| log D | 7.18 | pH 10; Temperatur: 25 °C | (1) ACD |
| logP | 9,038±0,723 | Temperatur: 25 °C | (1) ACD |
| Mass Intrinsesch Solubilitéit | 1,4 x 10-5 g/l | Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 0,014 g/l | pH 1; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 5,3 x 10-4 g/L | pH 2; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 5,3 x 10-5 g/l | pH 3; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,7 x 10-5 g/l | pH 4; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,3 x 10-5 g/l | pH 5; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,3 x 10-5 g/l | pH 6; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,7 x 10-5 g/l | pH 7; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 4,5 x 10-5 g/l | pH 8; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 2,8 x 10-4 g/L | pH 9; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 9,8 x 10-4 g/l | pH 10; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,7 x 10-5 g/l | Ongebuffert Waasser pH 6,99; Temperatur: 25 °C | (1) ACD |
| Molar Intrinsesch Solubilitéit | 1,6 x 10-8 mol/l | Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,6 x 10-5 mol/l | pH 1; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 6,0 x 10-7 mol/l | pH 2; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 6,0 x 10-8 mol/l | pH 3; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,9 x 10-8 mol/l | pH 4; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,5 x 10-8 mol/l | pH 5; Temperatur: 25 °C | (1) ACD |
| Immobilie | Wäert | Zoustand | Quell |
| Molar Solubilitéit | 1,5 x 10-8 mol/l | pH 6; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,9 x 10-8 mol/l | pH 7; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 5,1 x 10-8 mol/l | pH 8; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 3,1 x 10-7 mol/l | pH 9; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,1 x 10-6 mol/l | pH 10; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,9 x 10-8 mol/l | Ongebuffert Waasser pH 6,99; Temperatur: 25 °C | (1) ACD |
| Molekulare Gewiicht | 887,96 | ||
| pKa | 7,87±0,43 | Déi meescht sauer Temperatur: 25 °C | (1) ACD |
| pKa | 3,45±0,70 | Déi meescht Basistemperatur: 25 °C | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Zoustand | Quell |
| Fräi rotéierbar Obligatiounen | 19 | (1) ACD | |
| H Akzepter | 15 | (1) ACD | |
| H Donateuren | 1 | (1) ACD | |
| H Donateur / Akzeptanz Zomm | 16 | (1) ACD | |
| logP | 9,038±0,723 | Temperatur: 25 °C | (1) ACD |
| Molekulare Gewiicht | 887,96 |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Conditioun Quell |
| Polar Fläch Beräich | 178 A2 | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
Spektrum verfügbar
1H NMR
13 C NMR
| Code | Gefor Ausso | Quell |
| H335 | Kann Atmungsirritatioun verursaachen | Expert Curated |
| Code | Gefor Ausso | Quell |
| H331 | Gëfteg wann inhaléiert | Expert Curated |
| H319 | Verursacht sérieux Auge Reizung | Expert Curated |
| H315 | Verursacht Hautirritatiounen | Expert Curated |
| H311 | Gëfteg am Kontakt mat der Haut | Expert Curated |
| H301+H311+H331 | Gëfteg wann geschluecht, am Kontakt mat der Haut oder vun inhaléiert | Expert Curated |
| H301 | Gëfteg wann geschluecht | Expert Curated |
![C40H49N4O9P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C40H49N4O9P-Uridine-300x300.png)
![C45H56N7O9P Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N,N-bis (1-Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C45H56N7O9P-300x300.png)
![C44H53FN7O8 Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N, N-bis(1-Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C44H53FN7O8-300x300.png)
![C47H51FN7O7P Adenosin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- deoxy-2'-fluoro-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl) Phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C47H51FN7O7P-Adenosine-300x300.png)
![C41H49FN5O8P Cytidin, N-acetyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- deoxy-2'-fluoro-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl) Phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C41H49FN5O8P-Cytidine-300x300.png)
![C43H55N4O10P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)- 5-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-) Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C43H55N4O10P-Uridine-300x300.png)